US and India are having trade discussions. David Roche suggests caution. He thinks the US is eager for a deal. Trump uses tariffs as levera...

Roche Pharma India has announced that Rajwinder Mehdwan will take over as the country general manager from April 1, 2025, replacing V Simps...

Roche Diagnostics India, a part of the Roche Group, on Wednesday announced the appointment of Narendra Varde as Managing Director for India...

The result of the COVACTA study dashes the hopes of experts who were looking to use the rheumatoid arthritis drug as treatment option for C...

A Roche India spokesperson confirmed the development and said an announcement for a new India head will be made soon. “Dec. 1 will be the d...

Lara Bezerra, Roche Managing Director (India), who moved from the troubled Venezuela market to India, told ET that as part of its long-term...

In a foes-turn-friends move announced on February 27, the Mumbai-based drug maker announced that it will partner Swiss biotech company Roch...

Lara has over 24 years of experience in the pharmaceutical industry and was earlier the general manager of Roche Venezuela.

The companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first ...

Subramanyam succeeds Guido Sander, who has shifted to Singapore, to head high growth markets for Roche Diagnostics' Asia Pacific business.

The judge asked the company to submit a compilation of judgments highlighting the protection given to drug innovators to support its call.

Companies are experimenting with offers such as installments, free diagnostic tests, discounts and even tailor-made insurance schemes to ma...

These companies not only had to battle slow growth but also the fickle stand of Indian government over issues of intellectual property and ...

The development comes after a division bench of the Delhi HC referred the companies to a mediation that both firms chose to accept.

Swiss drug major Roche, which is often at logger heads with Indian generic drugmakers over patent rights, has made a shift in its strategy.

Cipla, the Indian drugmaker that built a $1-billion business making generic HIV treatments, aims to sell copies of Roche Holding's and Amge...

The momentum is likely to continue Thursday with the Nifty breaking out of a crucial resistance level of 2850. Also, increased FII activity...